삼성바이오로직스

207940KOSPI기초 의약물질 제조업

47.6 / 100

Reference Date: 2026-06-10

Financial Score15.5 / 40

News Sentiment15.1 / 25

Momentum5.0 / 20

Disclosure12.0 / 15

AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Declined 11.7% over the past month, and news sentiment is negative.

Company InformationBased on 2025 Annual Report

Business Overview

Samsung BioLogics is a global CDMO (Contract Development and Manufacturing Organization) providing biopharmaceutical contract manufacturing and development services. In 2025, it restructured into a pure-play CDMO business by spinning off Samsung Epics Holdings. The company generates significant revenue from Europe and the U.S. and is expanding into next-generation biopharmaceuticals such as mRNA, ADC, and cell/gene therapies.

Number of Employees

10,910people

Average Salary

114.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

33.62Industry Average 27.713.0Point

Higher than industry avg (caution)

PBR

8.05Industry Average 1.740.0Point

4.6x industry avg (risky)

ROE

19.44Industry Average -6.033.5Point

Well below industry avg

Debt Ratio

14.45Industry Average 6.620.0Point

2.2x industry avg (risky)

Trend 2023~20259.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲11.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲37.6% (2-year basis)

ROE Trend

3.5 / 4

Avg ROE 13.0% (improving, 3yr)

Detailed News Sentiment

74 totalPositive 15Neutral 40Negative 19Average Sentiment Score 60.3

Positive
[기획] 이재용 ‘AX혁명’… 삼성 DNA 통째 바꾼다
이재용의 AI 중심 전략 선언으로 삼성바이오로직스를 포함한 삼성그룹 전반에 혁신적 변화가 예상되며, 직원 교육을 통한 기술 전환 가속화로 긍정적 영향 기대.
Negative
삼성바이오 노조 "초기업노조 탈퇴"… 교섭 끝 안보인다
Union withdrawal at Samsung Bioscience raises concerns over operational stability and competitiveness amid industry-wide labor tensions.
Neutral
삼성바이오 노조, 삼성그룹 초기업노조 탈퇴 추진
삼성바이오로직스 노동조합이 삼성그룹 내 초기업 노조 탈퇴를 추진 중이지만, 구체적인 영향은 제한적입니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 1,296,000Won52-week high 1,965,00052-week low 1,296,000

1-month return1.0Point

1m -11.72% (falling)

Volume trend3.0Point

Volume flat

Detailed Disclosure

9 totalPositive 1Neutral 8Negative 0

Positive[기재정정]단일판매ㆍ공급계약체결2026-06-09
Neutral최대주주등소유주식변동신고서2026-06-01
Neutral특수관계인에대한출자2026-06-01
Neutral기업지배구조보고서공시2026-06-01
Neutral지속가능경영보고서등관련사항(자율공시)2026-06-01